Medical Weight Loss in El Paso,
Actually Supervised

Most adults with a BMI of 27 or above who have struggled with diet and exercise alone are candidates. Celeste will review your health history, labs, and goals at your consultation to determine the right approach for you.

Yes. Solas Health offers both semaglutide (Ozempic/Wegovy-class) and tirzepatide (Mounjaro/Zepbound-class) GLP-1 medications as part of supervised medical weight loss programs.

Results vary by individual, but patients on GLP-1 therapy with lifestyle support typically lose 10–20% of body weight over 3–6 months. Celeste monitors your progress and adjusts your plan throughout.

No referral needed. You can book a consultation directly through our website or by calling (915) 266-3174.

At Solas Health & Wellness, semaglutide programs start at $190 per month and tirzepatide programs start at $290 per month. Pricing includes your provider visits, dosing, and ongoing monitoring. We confirm your exact plan and cost at your consultation.

Solas is a self-pay clinic — we don't bill insurance, so there are no surprise codes or denials. Pricing is flat and transparent: semaglutide from $190/month and tirzepatide from $290/month, including your provider visits, dosing, and monitoring.

Solas is a locally owned El Paso clinic. You meet with Celeste in person, receive ongoing monitoring, labs, and adjustments — not just a prescription shipped to your door with no follow-up. You're a patient, not a subscription.

Solas Health & Wellness on El Paso's West Side (6633 N Mesa St) provides prescription weight loss medication — including semaglutide and tirzepatide — under the supervision of Celeste Cisneros, FNP-BC. Every plan starts with a consultation and labs. Book online or call (915) 266-3174.

Yes. Alongside GLP-1 therapy we offer supporting weight loss injections such as vitamin B12 and lipotropic (MIC) fat-burner shots, plus AOD peptide support, to help with energy, metabolism, and muscle preservation. Your provider will recommend what fits your plan.

We offer oral weight loss medication options, including appetite-management prescriptions, where they're appropriate for your health profile. Many patients do best on GLP-1 injections, but we build the plan around you after a full evaluation.

The best clinic diagnoses before it prescribes, monitors your labs and progress, and offers honest, transparent pricing. At Solas, every plan is lab-based and led by Celeste Cisneros, FNP-BC, with in-person follow-up — not a ship-it-and-forget-it subscription.

Solas Health & Wellness in El Paso offers non-surgical, medically supervised weight loss: GLP-1 injections including semaglutide (the medication in Ozempic and Wegovy) and tirzepatide (the medication in Mounjaro and Zepbound), plus AOD peptide therapy, lipotropic (MIC) and B12 fat-burner injections, and oral appetite-management options where appropriate. Every plan is lab-based and supervised by Celeste Cisneros, FNP-BC — no surgery, no devices, just prescription-grade medical weight loss.

Your monthly fee at Solas Health & Wellness covers in-clinic or telehealth provider visits with Celeste Cisneros, FNP-BC, dose adjustments, ongoing safety monitoring, and direct messaging with the clinic for routine questions between visits. The medication itself is billed by the pharmacy and lab work is billed by the lab directly — Solas does not mark either up. Semaglutide programs start at $190/month; tirzepatide programs start at $290/month.

Baseline labs typically include HbA1c, a Comprehensive Metabolic Panel (CMP), Lipid Panel, and Thyroid (TSH, Free T4). Depending on your history we may add a Complete Blood Count, lipase, and basic hormone markers. Labs are billed by the lab directly, not marked up. If your PCP has drawn similar labs in the last 6 months, bring them — we can often start from those.

Yes. Solas Health & Wellness sees medical weight loss patients from across the El Paso–Las Cruces borderplex, including El Paso, the Upper Valley, Canutillo, Vinton, Anthony (TX/NM), Sunland Park, Santa Teresa, Mesilla, Horizon City, and Las Cruces, NM. Celeste Cisneros, FNP-BC is licensed in both Texas and New Mexico, and GLP-1 medications can ship directly to your home from the pharmacy.

On average, tirzepatide produces greater weight loss than semaglutide in clinical trials — SURMOUNT-1 showed 22.5% average weight loss on tirzepatide vs roughly 15% on semaglutide. But 'better' depends on your individual response, side-effect tolerance, and budget. Semaglutide is typically lower cost. Many patients start with semaglutide and switch to tirzepatide if response plateaus. We'll talk through which fits you at your consultation — see our full comparison post for more depth.

Most patients lose 1–2% of body weight in the first month, accelerating to 4–8% by month three and 10–20% by month six — that's the typical clinical-trial pattern. The starting dose is intentionally low to minimize nausea, then we titrate up every 4 weeks based on your response and tolerance. Fastest results come from pairing the medication with consistent protein intake (0.7–1g per lb of target weight), strength training 2–3x/week, and 7–8 hours of sleep. NAD+ IV therapy is a common add-on to maintain energy during the calorie deficit.

If you stop GLP-1 therapy without a maintenance plan, weight regain is common — clinical trials show patients regain about two-thirds of the lost weight within a year of stopping. That's because the medication is doing real work on appetite signaling, and that signal returns when the medication stops. At Solas, we don't treat GLP-1 as forever-or-nothing: most patients reach their goal weight, then transition to a maintenance dose (often a lower dose, longer interval), or taper while building habits, lab markers, and supportive protocols (peptide therapy, lifestyle support) that hold the result. We plan the off-ramp at the start, not the end.

Yes — GLP-1 therapy is increasingly used as part of polycystic ovary syndrome (PCOS) management. Many PCOS patients have insulin resistance that drives weight gain and irregular cycles, and GLP-1 medications can improve insulin sensitivity alongside weight loss. We'll review your labs (including A1c, fasting insulin, and hormone panel) before starting and coordinate care if you're already being treated for PCOS by another provider.

The most common side effects are gastrointestinal: nausea, constipation, reflux, and sometimes diarrhea — usually mild, usually during the first weeks of a new dose. We start low and titrate slowly to minimize them. Less common but worth knowing: fatigue (especially during early calorie deficit — NAD+ IV therapy is a common add-on), gallbladder issues with rapid weight loss, and rare pancreatitis. We do NOT prescribe GLP-1 for patients with a personal or family history of medullary thyroid cancer or MEN2, history of pancreatitis, type 1 diabetes, or during pregnancy/breastfeeding. Side effects almost always improve when we adjust dose or timing — you'll have a direct line to Celeste if anything feels off.

Compounded GLP-1s come from licensed compounding pharmacies and use the same active ingredients as brand-name products, but the dosing forms, additives, and sourcing vary by pharmacy. Some compounded formulations are appropriate; others are not. The FDA's compounding rules around semaglutide and tirzepatide have shifted multiple times in the past year, so the safest path is to ask a real provider — not an online subscription — what they're using and where it comes from. See our full compounded-vs-brand breakdown for the current state.

Yes — some patients do best on a microdosing protocol where we keep the dose intentionally low (e.g. 0.125–0.25mg/wk semaglutide) for slower, gentler weight loss with fewer side effects, or for use after reaching goal weight as a maintenance dose. Microdosing isn't right for everyone — patients with significant weight to lose typically need standard titration to see meaningful results — but it's an option we discuss when it fits your goals and response.